Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Chagas disease continues to be a difficult disease to eradicate, largely because of the widespread populations it affects as well as the highly toxic effects of current therapies. Thus, the exploration of innovative scaffolds, ideally with distinct mechanisms of action, is urgently needed. The natural product aphidicolin and its effects on cell cycle division have been widely studied; it is a potent inhibitor of parasitic cells. In the present study, we report for the first time the semisynthesis of a series of aphidicolin derivatives, their unique structural features, and demonstration of their activity against Trypanosoma cruzi cells. Two demonstrated high potency and selectivity against parasitic amastigote cells, and thus show promise as new leads for Chagas disease treatment. Copyright © 2016 Elsevier Ltd. All rights reserved.

Citation

Gabriela B Santos, Renata Krogh, Luma G Magalhaes, Adriano D Andricopulo, Mônica T Pupo, Flavio S Emery. Semisynthesis of new aphidicolin derivatives with high activity against Trypanosoma cruzi. Bioorganic & medicinal chemistry letters. 2016 Feb 15;26(4):1205-8

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 26810263

View Full Text